Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Psychological intervention and antidepressant treatment in smoking cessation.

Hall SM, Humfleet GL, Reus VI, Muñoz RF, Hartz DT, Maude-Griffin R.

Arch Gen Psychiatry. 2002 Oct;59(10):930-6.

PMID:
12365880
2.

Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation.

Quaak M, van Schayck CP, Postma DS, Wagena EJ, van Schooten FJ.

Addiction. 2012 Jan;107(1):178-87. doi: 10.1111/j.1360-0443.2011.03534.x. Epub 2011 Sep 21.

PMID:
21658141
3.

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

Hall SM, Reus VI, Muñoz RF, Sees KL, Humfleet G, Hartz DT, Frederick S, Triffleman E.

Arch Gen Psychiatry. 1998 Aug;55(8):683-90.

PMID:
9707377
4.

Antidepressants for smoking cessation.

Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T.

Cochrane Database Syst Rev. 2014 Jan 8;(1):CD000031. doi: 10.1002/14651858.CD000031.pub4. Review.

PMID:
24402784
5.

Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation.

Hall SM, Lightwood JM, Humfleet GL, Bostrom A, Reus VI, Muñoz R.

J Behav Health Serv Res. 2005 Oct-Dec;32(4):381-92.

PMID:
16215448
6.

Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.

Wagena EJ, Knipschild PG, Huibers MJ, Wouters EF, van Schayck CP.

Arch Intern Med. 2005 Oct 24;165(19):2286-92.

PMID:
16246996
7.

A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results.

Haggsträm FM, Chatkin JM, Sussenbach-Vaz E, Cesari DH, Fam CF, Fritscher CC.

Pulm Pharmacol Ther. 2006;19(3):205-9. Epub 2006 Mar 6.

PMID:
16517193
8.

A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.

Evins AE, Culhane MA, Alpert JE, Pava J, Liese BS, Farabaugh A, Fava M.

J Clin Psychopharmacol. 2008 Dec;28(6):660-6. doi: 10.1097/JCP.0b013e31818ad7d6.

9.

Antidepressants for smoking cessation.

Hughes JR, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD000031. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD000031.

PMID:
17253443
10.

Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.

Aubin HJ, Lebargy F, Berlin I, Bidaut-Mazel C, Chemali-Hudry J, Lagrue G.

Addiction. 2004 Sep;99(9):1206-18.

PMID:
15317642
11.

Extended nortriptyline and psychological treatment for cigarette smoking.

Hall SM, Humfleet GL, Reus VI, Muñoz RF, Cullen J.

Am J Psychiatry. 2004 Nov;161(11):2100-7.

PMID:
15514412
12.

Smoking cessation interventions for smokers with current or past depression.

van der Meer RM, Willemsen MC, Smit F, Cuijpers P.

Cochrane Database Syst Rev. 2013 Aug 21;(8):CD006102. doi: 10.1002/14651858.CD006102.pub2. Review.

PMID:
23963776
13.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
14.

The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients.

Van Schayck CP, Kaper J, Wagena EJ, Wouters EF, Severens JL.

Addiction. 2009 Dec;104(12):2110-7. doi: 10.1111/j.1360-0443.2009.02723.x.

PMID:
19922576
15.

Antidepressants for smoking cessation.

Hughes J, Stead L, Lancaster T.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000031. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD000031.

PMID:
15494986
16.

Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

Cahill K, Stevens S, Perera R, Lancaster T.

Cochrane Database Syst Rev. 2013 May 31;(5):CD009329. doi: 10.1002/14651858.CD009329.pub2. Review.

PMID:
23728690
17.

Bupropion and cognitive-behavioral treatment for depression in smoking cessation.

Brown RA, Niaura R, Lloyd-Richardson EE, Strong DR, Kahler CW, Abrantes AM, Abrams D, Miller IW.

Nicotine Tob Res. 2007 Jul;9(7):721-30.

18.

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR; Varenicline Phase 3 Study Group.

JAMA. 2006 Jul 5;296(1):47-55.

PMID:
16820546
19.

Bupropion: a review of its use in the management of smoking cessation.

Holm KJ, Spencer CM.

Drugs. 2000 Apr;59(4):1007-24. Review.

PMID:
10804045
20.

CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.

Lee AM, Jepson C, Hoffmann E, Epstein L, Hawk LW, Lerman C, Tyndale RF.

Biol Psychiatry. 2007 Sep 15;62(6):635-41. Epub 2007 Jan 16.

PMID:
17223085

Supplemental Content

Support Center